Dow Up 0.91% Nasdaq Up 1.69%

Repligen Corporation (RGEN)

-NasdaqGS
22.61 Down 0.14(0.62%) 1:17PM EDT - Nasdaq Real Time Price
Prev Close:22.75
Open:22.87
Bid:22.69 x 100
Ask:22.73 x 500
1y Target Est:25.33
Beta:1.42
Next Earnings Date: 6-Nov-14RGEN Earnings announcement
Day's Range:22.55 - 22.95
52wk Range:9.97 - 24.68
Volume:115,925
Avg Vol (3m):386,969
Market Cap:738.17M
P/E (ttm):44.42
EPS (ttm):0.51
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for RGEN

Comparison

Symbol% ChgMkt Cap
RGENDown 0.62%738.17M
BIOUp 1.45%3.26B

Key Statistics

Forward P/E (1 yr):63.17
P/S (ttm):11.24
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :0.28
Quarterly EPS Est (Sep-14) :0.04
Mean Recommendation*:1.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Repligen Corporation, a life sciences company, develops, manufactures, and markets consumable bioprocessing products for use in the production of monoclonal antibodies and other biologic drugs. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback